logo
welcome
Medical Xpress - medical research advances and health news

Medical Xpress - medical research advances and health news

Scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects

Medical Xpress - medical research advances and health news
Summary
Nutrition label

89% Informative

New study establishes clonal hematopoiesis as a new risk factor for atherosclerosis.

Condition triggered by acquired mutations in blood stem cells and was already known to be associated with an elevated cardiovascular risk.

Researchers propose the ancient medication colchicine as the central plank of personalized strategies to alleviate the effects.

A new study shows the adverse effects of TET2 mutations on cardiovascular health can be alleviated by treatment with the anti-inflammatory drug colchicine.

The best characterized mutations linked to clonal hematopoiesis are those that affect the Tet2 gene.

The study lays the groundwork for using colchichine for/in the personalized prevention of cardiovascular disease.

VR Score

92

Informative language

96

Neutral language

21

Article tone

formal

Language

English

Language complexity

88

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

Affiliate links

no affiliate links